Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Expression of interleukin-27 (IL27) in human lower airways. Pathophysiological implications in pulmonary sarcoidosis (PS)

Piotr Kopinski, Tomasz Wandtke, Joanna Chorostowska-Wynimko, Grzegorz Przybylski, Ewelina Pólgesek, Andrzej Dyczek
European Respiratory Journal 2012 40: P3613; DOI:
Piotr Kopinski
1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomasz Wandtke
1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Chorostowska-Wynimko
2Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grzegorz Przybylski
3Dept. of Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewelina Pólgesek
1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrzej Dyczek
2Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. Suppl 56

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online July 25, 2014.

Copyright & Usage 
© 2012 ERS

Author Information

  1. Piotr Kopinski1,
  2. Tomasz Wandtke1,
  3. Joanna Chorostowska-Wynimko2,
  4. Grzegorz Przybylski3,
  5. Ewelina Pólgesek1 and
  6. Andrzej Dyczek2
  1. 1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
  2. 2Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, Poland
  3. 3Dept. of Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

Article usage

Article usage: August 2014 to January 2023

AbstractFullPdf
Aug 2014200
Sep 2014201
Oct 2014400
Nov 2014201
Jan 2015300
Mar 2015001
May 2015200
Jun 2015300
Jul 2015100
Aug 2015201
Sep 2015200
Oct 2015100
Dec 2015605
Jan 2016001
Feb 2016601
Mar 2016100
Apr 2016005
May 2016007
Jun 2016203
Jul 2016105
Aug 2016004
Sep 2016800
Oct 2016405
Nov 2016400
Dec 2016101
Jan 2017201
Feb 2017702
Mar 2017100
Apr 2017100
May 2017300
Jun 2017100
Jul 2017101
Aug 2017400
Sep 2017207
Oct 20175014
Nov 2017206
Dec 2017304
Jan 2018700
Feb 20181010
Mar 2018209
Apr 20181012
May 20181014
Jun 2018203
Jul 2018305
Aug 2018504
Sep 20182010
Oct 20188017
Nov 20189017
Dec 2018003
Jan 2019100
Mar 2019102
Apr 2019100
May 2019100
Jun 2019302
Jul 2019501
Aug 2019101
Sep 2019202
Oct 2019001
Nov 2019200
Dec 2019200
Jan 2020402
Feb 2020501
Mar 2020800
Apr 2020601
Jun 2020300
Jul 2020100
Aug 2020501
Sep 20202100
Oct 2020800
Nov 2020201
Dec 2020402
Jan 2021203
Feb 2021201
Mar 2021200
Apr 2021200
May 2021301
Jun 20211001
Jul 2021500
Aug 2021703
Sep 2021600
Oct 2021300
Nov 202111012
Dec 2021500
Jan 20221505
Feb 2022300
Mar 2022604
Apr 2022302
May 2022200
Jun 2022600
Jul 20221405
Aug 2022304
Sep 2022202
Oct 2022400
Nov 2022400
Dec 2022300
Jan 2023101

Altmetrics

Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Expression of interleukin-27 (IL27) in human lower airways. Pathophysiological implications in pulmonary sarcoidosis (PS)
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Expression of interleukin-27 (IL27) in human lower airways. Pathophysiological implications in pulmonary sarcoidosis (PS)
Piotr Kopinski, Tomasz Wandtke, Joanna Chorostowska-Wynimko, Grzegorz Przybylski, Ewelina Pólgesek, Andrzej Dyczek
European Respiratory Journal Sep 2012, 40 (Suppl 56) P3613;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Expression of interleukin-27 (IL27) in human lower airways. Pathophysiological implications in pulmonary sarcoidosis (PS)
Piotr Kopinski, Tomasz Wandtke, Joanna Chorostowska-Wynimko, Grzegorz Przybylski, Ewelina Pólgesek, Andrzej Dyczek
European Respiratory Journal Sep 2012, 40 (Suppl 56) P3613;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
  • Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
  • Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features
Show more 1.5 Diffuse Parenchymal Lung Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society